Planned cesarean before labor onset for persistent previa
Maternal versus fetal risk balancing
Delivery for maternal instability regardless of gestational age
Expectant management when stable to reduce prematurity
Resource intensity
Blood bank coordination central to safe outcomes
Multidisciplinary planning for suspected accreta
Patient Discharge Instructions
copy discharge instructions
Discharge guidance for stable patients
Return immediately for bleeding
Any vaginal bleeding
Bleeding soaking a pad in 1 hour
Passage of clots
Return immediately for maternal symptoms
Dizziness or fainting
Shortness of breath
Chest pain
Severe weakness
Return immediately for fetal concerns
Decreased fetal movement
Persistent contractions or cramping
Fluid leakage
Activity restrictions
Pelvic rest
Avoid intercourse
Avoid inserting anything into vagina
Follow-up plan
Obstetric follow-up within timeframe specified by treating team
Scheduled ultrasound follow-up for placental position
Emergency readiness
Keep hospital contact numbers accessible
Transportation plan for urgent return
References
Clinical guidelines and consensus
Society for Maternal-Fetal Medicine Consult Series guidance on late preterm bleeding and delivery thresholds
Third-trimester bleeding framework for 34 0/7 to 36 6/7 weeks
Delivery threshold individualized by stability and etiology
Royal College of Obstetricians and Gynaecologists Green-top Guideline No. 27a
Placenta praevia and placenta accreta diagnosis and management pathway
Delivery planning in units with blood and critical care access
ACOG Obstetric Care Consensus on placenta accreta spectrum
Planned delivery window for suspected accreta spectrum at experienced centers
Multidisciplinary team recommendation
Evidence summaries and reviews
StatPearls placenta previa review for presentation patterns and accreta linkage
Institutional protocols for follow-up ultrasound timing and hemorrhage lab interpretation
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.